Confidently Navigating ADPKD: Understanding the New KDIGO Guideline, Decoding ADPKD: Beyond the Kidneys – The Whole-Body Impact of ADPKD

ADPKD affects more than just the kidneys. In part three of our four-part series, we’ll explore how ADPKD impacts the heart, liver, bones, and metabolic health.

Learning Objectives:

• Heart and vascular risks in ADPKD, including brain aneurysms.
• Polycystic liver disease (PLD) and how to manage symptoms.
• The impact of ADPKD on bone health, metabolism, and urinary health.
• Preventive care strategies for whole-body health

Speakers:

• Craig Gordon, M.D., M.S.: Director of the PKD Foundation Center of Excellence at Tufts Medical Center
• Pranav Garimella, MBBS, MPH, FASN: Director of the PKD Foundation Center of Excellence at University of California San Diego

*The Kidney Disease: Improving Global Outcomes (KDIGO) 2024 Guidelines for ADPKD provide the latest evidence-based recommendations to help patients, caregivers, and healthcare providers navigate the complexities of autosomal dominant polycystic kidney disease (ADPKD). Our 4-part educational series is designed to help patients and families better understand the latest KDIGO recommendations for ADPKD management.

This webinar is supported by a sponsorship from Otsuka. The PKD Foundation retains full control over the content and speaker selection to ensure unbiased, high-quality education for our community.